Correlation Between Amphastar and Dr Reddys
Can any of the company-specific risk be diversified away by investing in both Amphastar and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amphastar and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amphastar P and Dr Reddys Laboratories, you can compare the effects of market volatilities on Amphastar and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amphastar with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amphastar and Dr Reddys.
Diversification Opportunities for Amphastar and Dr Reddys
Modest diversification
The 3 months correlation between Amphastar and RDY is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Amphastar P and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Amphastar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amphastar P are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Amphastar i.e., Amphastar and Dr Reddys go up and down completely randomly.
Pair Corralation between Amphastar and Dr Reddys
Given the investment horizon of 90 days Amphastar P is expected to under-perform the Dr Reddys. In addition to that, Amphastar is 2.04 times more volatile than Dr Reddys Laboratories. It trades about -0.11 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about -0.18 per unit of volatility. If you would invest 1,528 in Dr Reddys Laboratories on August 26, 2024 and sell it today you would lose (108.00) from holding Dr Reddys Laboratories or give up 7.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amphastar P vs. Dr Reddys Laboratories
Performance |
| Timeline |
| Amphastar P |
| Dr Reddys Laboratories |
Amphastar and Dr Reddys Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amphastar and Dr Reddys
The main advantage of trading using opposite Amphastar and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amphastar position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.| Amphastar vs. Collegium Pharmaceutical | Amphastar vs. Alkermes Plc | Amphastar vs. Evolus Inc | Amphastar vs. Neurocrine Biosciences |
| Dr Reddys vs. Pacira BioSciences, | Dr Reddys vs. Phibro Animal Health | Dr Reddys vs. Collegium Pharmaceutical | Dr Reddys vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |